NVST Congressional Stock Trades

Envista Holdings Corporation

Last disclosed trade Jun 6

Every disclosed trade in NVST by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice. See every healthcare stock Congress trades.

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Pete Sessions · Sold $NVST · Jun 6 · $1K–$15K

0.58MED
Disclosure speedx 0.251.00
Trade sizex 0.250.20
Cluster activityx 0.150.00
Track recordx 0.350.80

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow $NVST

Get notified when any member of Congress trades $NVST. Free, no card, no spam.

Follow free →
1
Disclosed trades
0
Buys
1
Sales
1
Members trading

The record on $NVST

Coldpine has parsed 1 disclosed trade in $NVST by 1 member of Congress, drawn from 1 periodic transaction report dated Jun 6, 2024. It came from the House, filed by a Republican.

The one trade with a known filing lag was reported 0 days after the trade date, inside the 45-day window the STOCK Act sets: a $NVST sale by Pete Sessions dated Jun 6, 2024, disclosed Jun 6, 2024. How late filing is measured across all of Congress is in the late-filers study.

The one trade that lists an account holder was reported under a spouse, dependent child, or joint account rather than the member directly.

Members who trade NVST

Recent disclosed trades in NVST

DateMemberTypeAmount
Jun 6Pete Sessions(TX)sell$1K–$15K

From Coldpine Research

Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →